Capital Cell — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Amadixamadix.com in 𝕏Mar 2022

Amadix develops blood-based diagnostic tests for early cancer detection before symptoms appear.

AI & Machine LearningBiotechDigital HealthMedical Devices

Co-investorsDozen Investments CRB Inverbío

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.